Biopharma embraces Obama 'BRAIN' plan
This article was originally published in Scrip
Executive Summary
Although the overall costs and scale of President Barack Obama's BRAIN initiative are not yet known, and there's some skepticism about whether such a grand project should be under federal control using taxpayer dollars, many in the biopharmaceutical industry agreed with National Institutes of Health Director Dr Francis Collins the venture to map the human brain is "an idea whose time has come."